Search
for
Sort by
Research 31–60 of 1000+
- A trial of 1% minoxidil used topically for severe alopecia areata.
- EU Legal and Regulatory Update
- Court of Appeal can overrule itself to follow the EPO: UK adopts EPO stance on second medical use claims
- Negative term supplementary protection certificates granted by UK Intellectual Property Office
- Topical MK-386 (M), an inhibitor of 5α-reductase (5αr) type I, suppresses sebum dht.
- Enteral nutrition for maintenance of remission in Crohn's disease
- Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
- Alopecia - the search for novel agents continues
- Foundations of Bayesian Networks
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement
- Finasteride and male infertility: a case for prospective collaborative research databases?
- 'The Byzantine logic of patent law jurisprudence': patent protection for dosage regimes revisited
- Use finasteride for hair loss in men only
- Correction: Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Age, What Age, How Old?
- Patentability of dosage regime invention in the form of Swiss-type claim under Chinese patent law
- Generic competition and pharma patent strategies - a sequel
- Regulation and Implementation of Pharmaceutical and Other Regulations
- UK High Court Revokes Escitalopram UK Patent; Validity of Second Medical use Claims Based on Dosage Regimes in the UK; Stay of Proceedings in the UK Courts Pending EPO Opposition Proceedings
- News in brief
- The mineralization of hair follicle tissue
- Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data
- Attitudes and practices of dermatologists and primary care physicians who treat patients for MPHL: results of a survey
- Patent Evaluation: Δ-4,6-Steroids as Potent 5α-Reductase Inhibitors
- A new model of blood vessel remodeling
- Hair loss in psychopharmacology.
- Hair Loss in Psychopharmacology
- Control of myeloid cell density in barrier tissues
- STIM1 R304W in mice causes subgingival hair growth and an increased fraction of trabecular bone